Detalhe da pesquisa
1.
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.
N Engl J Med
; 388(23): 2159-2170, 2023 Jun 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36972022
2.
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.
N Engl J Med
; 381(20): 1929-1939, 2019 11 14.
Artigo
Inglês
| MEDLINE | ID: mdl-31722153
3.
What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer.
Gynecol Oncol
; 166(3): 410-416, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35835612
4.
Correlation of imaging and plasma based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC).
Gynecol Oncol
; 161(2): 382-388, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33712274
5.
The GOG partners: A program for industry sponsored clinical trials in gynecologic oncology within the GOG foundation.
Gynecol Oncol
; 162(1): 203-209, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33722417
6.
What happened to the US cancer cooperative groups? A status update ten years after the Institute of Medicine report.
Cancer
; 126(23): 5022-5029, 2020 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32970346
7.
Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group study.
Gynecol Oncol
; 159(1): 79-87, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32723679
8.
A randomized phase II study of cabozantinib versus weekly paclitaxel in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 152(3): 548-553, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30587441
9.
Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients.
Gynecol Oncol
; 154(2): 420-425, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31229298
10.
Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study.
Br J Cancer
; 118(2): 162-170, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29182608
11.
Identification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial.
Radiology
; 287(1): 176-184, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29185901
12.
Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 149(3): 525-530, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29550184
13.
Pre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: An NRG oncology group/gynecologic oncology group study.
Gynecol Oncol
; 150(2): 300-305, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29807694
14.
Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 18(6): 779-791, 2017 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28438473
15.
Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.
Cancer
; 123(7): 1144-1155, 2017 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27926776
16.
Utility of PET/CT to Evaluate Retroperitoneal Lymph Node Metastasis in High-Risk Endometrial Cancer: Results of ACRIN 6671/GOG 0233 Trial.
Radiology
; 283(2): 450-459, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28051912
17.
Effectiveness of cyanoacrylate microbial sealant in the reduction of surgical site infection in gynecologic oncology procedures: A phase III single institution prospective randomized trial.
Gynecol Oncol
; 144(1): 193-199, 2017 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-27836205
18.
FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 145(2): 366-373, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28314589
19.
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.
Gynecol Oncol
; 147(2): 243-249, 2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-28807367
20.
Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 147(3): 648-653, 2017 12.
Artigo
Inglês
| MEDLINE | ID: mdl-28969912